Rights and permissions
About this article
Cite this article
Costs associated with triple screening for Down's syndrome. Pharmacoecon. Outcomes News 350, 3–4 (2002). https://doi.org/10.1007/BF03278683
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03278683